TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Affinia Therapeutics Stock

Affinia Therapeutics Stock

affiniatx.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $179.09MM

Affinia Therapeutics’ purpose is to develop gene therapies that can have a transformative impact on people affected by devastating rare and non-rare diseases and methodically engineers novel AAV vectors and regulatory elements to make gene therapies with potentially improved tissue tropism, cell specificity, safety, and yields.

Buy or sell Affinia Therapeutics stockLearn more about Affinia Therapeutics IPO
Register To Buy and Sell Shares

For more details on financing and valuation for Affinia Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Affinia Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Affinia Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Affinia Therapeutics’ Stock

Can you buy Affinia Therapeutics stock?
Affinia Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Affinia Therapeutics stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Affinia Therapeutics stock?
Yes, you can sell stock of a private company like Affinia Therapeutics. Forge can help you sell your Affinia Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Affinia Therapeutics’ stock price?
Affinia Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Affinia Therapeutics’ private market stock price with Forge Data.
What is Affinia Therapeutics’ stock ticker symbol?
Affinia Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Affinia Therapeutics in the BioTech & Pharma sector

ANDE

Sector
Healthcare / BioTech & Pharma
 
 

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$3.67B

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Neumora

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.45B

Life Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$500MM

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$303.94MM

Biosplice Therapeutics

Sector
Healthcare / BioTech & Pharma
 
 

Atomwise

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$405.17MM

Trending Companies

Frequently Asked Questions

Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.